Phosphorylated tau potentiates Aβ-induced mitochondrial damage in mature neurons

Neurobiology of Disease

Volumn 71, Issue , 2014, Pages 260-269

  Quintanilla, Rodrigo A ^a,b   von Bernhardi, Rommy ^b   Godoy, Juan A ^d   Inestrosa, Nibaldo C ^d   Johnson, Gail V W ^c  

^a UNIVERSIDAD AUTÓNOMA DE CHILE   (Chile)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^d PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Alzheimer's disease; Mitochondria; Neuronal dysfunction; PHF 1; Tau

Indexed keywords

AMYLOID PRECURSOR PROTEIN; GREEN FLUORESCENT PROTEIN; PRESENILIN 1; SUPEROXIDE; TAU PROTEIN;

ANIMAL; ANIMAL EMBRYO; BRAIN CORTEX; C57BL MOUSE; CELL CULTURE; CHEMICALLY INDUCED; CYTOLOGY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG EFFECTS; GENETIC TRANSFECTION; GENETICS; METABOLISM; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; MUTATION; NERVE CELL; PHOSPHORYLATION; RAT; TRANSGENIC MOUSE;

AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; CELLS, CULTURED; CEREBRAL CORTEX; EMBRYO, MAMMALIAN; GREEN FLUORESCENT PROTEINS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MITOCHONDRIAL DISEASES; MUTATION; NEURONS; PHOSPHORYLATION; PRESENILIN-1; RATS; SUPEROXIDES; TAU PROTEINS; TRANSFECTION;

EID: 84908210642     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2014.08.016     Document Type: Article

References (42)

1. Alonso A.C., Li B., Grundke-Iqbal I., Iqbal K. Mechanism of tau-induced neurodegeneration in Alzheimer disease and related tauopathies. Curr. Alzheimer Res. 2008, 5:375-384.
2. Brennan A.M., Wong S.W., Won S.J., Narasimhan P., Kauppinen T.M., Lee H., Edling Y., Chan P.H., Swanson R.A. NADPH oxidase is the primary source of superoxide induced by NMDA receptor activation. Nat. Neurosci. 2009, 12:857-863.
3. Brookes P.S., Yoon Y., Robotham J.L., Anders M.W., Sheu S.S. Calcium, ATP, and ROS: a mitochondrial love-hate triangle. Am. J. Physiol. Cell Physiol. 2004, 287:C817-C833.
4. Bubber P., Haroutunian V., Fisch G., Blass J.P., Gibson J.E. Mitochondrial abnormalities in Alzheimer brain: mechanistic implications. Ann. Neurol. 2005, 57:695-703.
5. Busciglio J., Lorenzo A., Yeh J., Yankner B.A. β-Amyloid fibrils induce tau phosphorylation and loss of microtubule binding. Neuron 1995, 14:879-888.
6. Cancino G.I., Perez de Arce K., Castro P.U., Toledo E.M., Bernhardi von R., Alvarez A.R. c-Abl tyrosine kinase modulates tau pathology and Cdk5 phosphorylation in AD transgenic mice. Neurobiol. Aging 2011, 32:1249-1261.
7. de Calignon A., Fox L.M., Pitstick R., Carlson G.A., Bacskai B.J., Spires-Jones T.L., Hyman B.T. Caspase activation precedes and leads to tangles. Nature 2010, 464:1201-1204.
8. Ding H., Matthews T.A., Johnson G.V.W. Site-specific phosphorylation and caspase cleavage differentially impact tau-microtubule interactions and tau aggregation. J. Biol. Chem. 2006, 281:19107-19114.
9. Gamblin T.C., Chen F., Zambrano A., Abraha A., Lagalwar S., Guillozet A.L., Lu M., Fu Y., Garcia-Sierra F., LaPointe N., Miller R., Berry R.W., Binder L.I., Cryns V.L. Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:10032-10037.
10. Grundke-Iqbal I., Iqbal K., Quinlan M., Tung Y.C., Zaidi M.S., Wisniewski H.M. Microtubule-associated protein tau. A component of Alzheimer paired helical filaments. J. Biol. Chem. 1986, 261:6084-6089.
11. Grundke-Iqbal I., Iqbal K., Tung Y.C., Quinlan M., Wisniewski H.M., Binder L.I. Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc. Natl. Acad. Sci. U. S. A. 1986, 83:4913-4917.
12. Höglinger G.U., Lannuzel A., Khondiker M.E., Michel P.P., Duyckaerts C., Feger J., Champy P., Prigent A., Medja F., Lombes A., Oertel W.H., Ruberg M., Hirsch E.C. The mitochondrial complex I inhibitor rotenone triggers a cerebral tauopathy. J. Neurochem. 2005, 95:930-939.
13. Hwan-Ching Tai A.S., Serrano-Pozo A., Hashimoto T., Frosch M.P., Spires-Jones T.L., Hyman B.T. The synaptic accumulation of hyperphosphorylated tau oligomers in Alzheimer disease is associated with dysfunction of the ubiquitin-proteasome system. Am. J. Pathol. 2012, 181:1426-1435.
14. Ihara Y., Nukina N., Miura R., Ogawara M. Phosphorylated tau protein is integrated into paired helicalfilaments in Alzheimer's disease. J. Biochem. 1986, 99:1807-1810.
15. Ittner L.M., Ke Y.D., Delerue F., Bi M., Gladbach A., van Eersel J., Wölfing H., Chieng B.C., Christie M.J., Napier I.A., Eckert A., Staufenbiel M., Hardeman E., Götz J. Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models. Cell 2010, 142:e387-e397.
16. Johnson G.V.W., Stoothoff W.H. Tau phosphorylation in neuronal cell function and dysfunction. J. Cell Sci. 2004, 117:5721-5729.
17. Kosik K.S., Joachim C.L., Selkoe D.J. Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease. Proc. Natl. Acad. Sci. U. S. A. 1986, 83:4044-4048.
18. Leroy K., Ando K., Laporte V., Dedecker R., Suain V., Authelet M., Héraud C., Pierrot N., Yilmaz Z., Octave J.N., Brion J.P. Lack of tau proteins rescues neuronal cell death and decreases amyloidogenic processing of APP in APP/PS1 mice. Am. J. Pathol. 2012, 181:1928-1940.
19. Manczak M., Reddy P.H. Abnormal interaction between the mitochondrial fission protein Drp1 and hyperphosphorylated tau in Alzheimer's disease neurons: implications for mitochondrial dysfunction and neuronal damage. Hum. Mol. Genet. 2012, 21:2538-2547.
20. Mandelkow E.M., Stamer K., Vogel R., Thies E., Mandelkow E. Clogging of axons by tau, inhibition of axonal traffic and starvation of synapses. Neurobiol. Aging 2003, 24:1079-1085.
21. Matthews-Roberson T.A., Quintanilla R.A., Ding H., Johnson G.V. Immortalized cortical neurons expressing caspase-cleaved tau are sensitized to endoplasmic reticulum stress induced cell death. Brain Res. 2008, 1234:206-212.
22. Melov S., Adlard P.A., Morten K., Johnson F., Golden T.R., Hinerfeld D., Schilling B., Mavros C., Masters C.L., Volitakis I., Li Q.X., Laughton K., Hubbard A., Cherny R.A., Gibson B., Bush A.I. Mitochondrial oxidative stress causes hyperphosphorylation of tau. PLoS One 2007, 2:e536.
23. Pritchard S.M., Dolan P.J., Vitkus A., Johnson G.V.W. The toxicity of tau in Alzheimer disease: turnover, targets and potential therapeutics. Ann. N. Y. Acad. Sci. 2011, 15:1621-1635.
24. Quintanilla R.A., Muñoz F.J., Metcalfe M.J., Hitschfeld M., Olivares G., Godoy J.A., Inestrosa N.C. Trolox and 17beta-estradiol protect against amyloid beta-peptide neurotoxicity by a mechanism that involves modulation of the Wnt signaling pathway. J. Biol. Chem. 2005, 280:11615-11625.
25. Quintanilla R.A., Matthews-Roberson T.A., Dolan P.J., Johnson G.V. Caspase-cleaved tau expression induces mitochondrial dysfunction in immortalized cortical neurons: implications for the pathogenesis of Alzheimer disease. J. Biol. Chem. 2009, 284:18754-18766.
26. Quintanilla R.A., Dolan P.J., Jin Y.N., Johnson G.V.W. Truncated tau and Aβ cooperatively impair mitochondria in primary neurons. Neurobiol. Aging 2012, 33:e25-e35.
27. Quintanilla R.A., Orellana J.A., Bernhardi von R. Understanding risk factors for Alzheimer's disease: interplay of neuroinflammation, connexin-based communication and oxidative stress. Arch. Med. Res. 2012, 43:632-644.
28. Rapoport M., Dawson H.N., Binder L.I., Vitek M.P., Ferreira A. Tau is essential to beta-amyloid-induced neurotoxicity. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:6364-6369.
29. Reddy P.H. Amyloid precursor protein-mediated free radicals and oxidative damage: implications for the development and progression of Alzheimer's disease. J. Neurochem. 2006, 96:1-13.
30. Reddy P.H. Abnormal tau, mitochondrial dysfunction, impaired axonal transport of mitochondria, and synaptic deprivation in Alzheimer's disease. Brain Res. 2011, 1415:e136-e148.
31. Reynolds M.R., Berry R.W., Binder L.I. Nitration in neurodegeneration: deciphering the "Hows" "nYs". Biochemistry 2007, 46:7325-7336.
32. Roberson E.D., Scearce-Levie K., Palop J.J., Yan F., Cheng I.H., Wu T., Gerstein H., Yu G.Q., Mucke L. Reducing endogenous tau ameliorates amyloid beta induced deficits in an Alzheimer's disease mouse model. Science 2007, 316:750-754.
33. Shahani N., Subramaniam S., Wolf T., Tackenberg C., Brandt R. Tau aggregation and progressive neuronal degeneration in the absence of changes in spine density and morphology after targeted expression of Alzheimer's disease-relevant tau constructs in organotypic hippocampal slices. J. Neurosci. 2006, 26:6103-6114.
34. Shahpasand K., Uemura I., Saito T., Asano T., Hata K., Shibata K., Toyoshima Y., Hasegawa M., Hisanaga S. Regulation of mitochondrial transport and inter-microtubule spacing by tau phosphorylation at the sites hyperphosphorylated in Alzheimer's disease. J. Neurosci. 2012, 32:2430-2441.
35. Spires-Jones T.L., de Calignon A., Matsui T., Zehr C., Pitstick R., Wu H.-Y., Osetek J.D., et al. In vivo imaging reveals dissociation between caspase activation and acute neuronal death in tangle-bearing neurons. J. Neurosci. 2008, 28:862-867.
36. Stokin G.B., Lillo C., Falzone T.L., Brusch R.G., Rockenstein E., Mount S.L., Raman R., Davies P., Masliah E., Williams D.S., Goldstein L.S. Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease. Science 2005, 307:1282-1288.
37. Stoothoff W., Jones P.B., Spires-Jones T.L., Joyner D., Chhabra E., Bercury K., Fan Z., Xie H., Bacskai B.J., Irimia D., Hyman B.T. Differential effect of three-repeat and four-repeat tau on mitochondrial axonal transport. J. Neurochem. 2009, 111:417-427.
38. Trushina E., Nemutlu E., Chang S., Christensen T., Camp J., Mesa J., Siddiqui A., Tamura Y., Sesaki H., Wengenack T.M., Dzeja P.P., Poduslo J.F. Defects in mitochondrial dynamics and metabolomic signatures of evolving energetic stress in mouse models of familial Alzheimer's disease. PLoS One 2012, 7:e32737.
39. Varela-Nallar L., Alfaro I.E., Serrano F.G., Parodi J., Inestrosa N.C. Wingless-type family member 5A (Wnt-5a) stimulates synaptic differentiation and function of glutamatergic synapses. Proc. Natl. Acad. Sci. 2010, 107:21164-21169.
40. von Bernhardi R., Eugenín J. Alzheimer's disease: redox dysregulation as a common denominator for diverse pathogenic mechanisms. Antioxid. Redox Signal. 2012, 16:974-1031.
41. Vossel K.A., Zhang K., Brodbeck J., Daub A.C., Sharma P., Finkbeiner S., Cui B., Mucke L. Tau reduction prevents Abeta-induced defects in axonal transport. Science 2010, 330:198.
42. Yeh P.A., Chang C.J., Tu P.H., Wilson H.I., Chien J.Y., Tang C.Y., Su M.T. Phosphorylation alters tau distribution and elongates life span in Drosophila. J. Alzheimers Dis. 2010, 21:543-556.